Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.
Just as a proposal to return JavaFX to the Java Development Kit has drawn interest in the OpenJDK community, Oracle too says ...
JDK 25 brings powerful new features to Java and JVM developers. Here are seven new or updated features that could convince ...
TipRanks on MSN
Roche Exercises Option with Recursion Pharmaceuticals
An announcement from Recursion Pharmaceuticals ( ($RXRX) ) is now available. On October 29, 2025, Recursion Pharmaceuticals announced that Roche ...
Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and report its third quarter 2025 ...
Microsoft introduced a new video series that teaches Java developers how to build generative AI applications using modern ...
Recursion Pharmaceuticals (NASDAQ:RXRX), a $2.3 billion market cap biotech company currently trading at $5.31, saw Chief Executive Officer Christopher Gibson sell 100,000 shares of Class A Common ...
There are no SEC filings that match your filter(s), please update your selections to return more records. Nasdaq provides company’s SEC filings, which are financial statements and reports filed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback